Prism Advisors, Inc. Teva Pharmaceutical Industries LTD Transaction History

Prism Advisors, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 15, 2021	SELL	$10.34 - $12.81 $106,967 - $132,519	-10,345 Closed	0 $0
Q2 2020 Jul 20, 2020	SELL	$8.12 - $13.12 $2.44 Million - $3.94 Million	-300,008 Reduced 96.67%	10,345 $128,000
Q1 2020 Apr 14, 2020	BUY	$6.69 - $13.45 $49,479 - $99,476	7,396 Added 2.44%	310,353 $2.79 Million
Q4 2019 Jan 23, 2020	BUY	$6.53 - $10.72 $186,646 - $306,409	28,583 Added 10.42%	302,957 $2.97 Million
Q3 2019 Oct 30, 2019	BUY	$6.16 - $9.6 $516,343 - $804,691	83,822 Added 43.99%	274,374 $1.89 Million
Q2 2019 Aug 06, 2019	BUY	$8.12 - $15.72 $490,220 - $949,047	60,372 Added 46.38%	190,552 $1.76 Million
Q1 2019 May 06, 2019	BUY	$15.58 - $20.01 $234,821 - $301,590	15,072 Added 13.09%	130,180 $2.04 Million
Q4 2018 Jan 22, 2019	SELL	$14.59 - $23.84 $33,425 - $54,617	-2,291 Reduced 1.95%	115,108 $1.78 Million
Q3 2018 Oct 26, 2018	SELL	$21.06 - $25.65 $310,677 - $378,388	-14,752 Reduced 11.16%	117,399 $2.49 Million
Q2 2018 Jul 13, 2018	SELL	$16.77 - $24.71 $93,308 - $137,486	-5,564 Reduced 4.04%	132,151 $3.19 Million
Q1 2018 Jun 05, 2018	BUY	$16.68 - $22.07 $2,518 - $3,332	151 Added 0.11%	137,715 $2.65 Million
Q1 2018 May 09, 2018	SELL	$16.68 - $22.07 $649,635 - $859,560	-38,947 Reduced 22.06%	137,564 $2.56 Million
Q4 2017 Feb 12, 2018	BUY	$11.23 - $19.1 $1.98 Million - $3.37 Million	176,511	176,511 $3.35 Million

629

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $24.1B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Prism Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Prism Advisors, Inc. with notifications on news.